BIOCODEX

biocodex-logo

Biocodex is an independent multinational pharmaceutical company built on high-standards science and manufacturing, with six decades of proven success. Founded in 1953, the companyโ€™s initial focus was gastroenterology featuring a unique probiotic Saccharomyces boulardii CNCM I-745ยฎ, the first probiotic drug of its kind that has a positive effect on the gutโ€™s microflora. Today, Biocodex has transformed itself beyond its probiotic drug roots, expanding its portfolio into a multitude of therapeutic areas which include:

#People #Financial #Website #More

BIOCODEX

Social Links:

Industry:
Manufacturing Pharmaceutical

Founded:
1953-01-01

Address:
France, Idaho, United States

Country:
United States

Website Url:
http://www.biocodex.fr

Total Employee:
5001+

Status:
Active

Contact:
+33 (0)1 41 24 30 00

Technology used in webpage:
Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sitelinks Search Box Euro Amazon Organization Schema IPv6 Google Maps Yoast SEO Premium


Current Employees Featured

nicolas-coudurier_image

Nicolas Coudurier
Nicolas Coudurier Founder & CEO @ BIOCODEX
Founder & CEO
2021-01-01

Founder


nicolas-coudurier_image

Nicolas Coudurier

Acquisitions List

Date Company Article Price
2020-01-06 Laboratoires IPRAD Laboratoires IPRAD acquired by BIOCODEX N/A

Official Site Inspections

http://www.biocodex.fr Semrush global rank: 3.74 M Semrush visits lastest month: 3.64 K

  • Host name: cdn.perf1.com
  • IP address: 152.89.172.56
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "BIOCODEX"

Home Page - Biocodex.com

Biocodex is a family-owned company founded more than 60 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded โ€ฆSee details»

Biocodex providing healthcare solutions worldwide. - Biocodexโ€ฆ

Biocodex is a family-owned company founded 70 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded its โ€ฆSee details»

REMINDER โ€“ Biocodex Microbiota Foundation invites Canadian โ€ฆ

2 days ago REMINDER โ€“ Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for โ‚ฌ35,000 research grant The objective is to advance microbiotaโ€™s role โ€ฆSee details»

BIOCODEX - YouTube

A family-owned French pharmaceutical laboratory established in 1953, Biocodex is a group that puts life at the service of life, placing health and its balances at the heart of its corporate ...See details»

Biocodex in Canada

Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its โ€ฆSee details»

Our products - Biocodex USA

Neurology is an important pillar to the Biocodex ecosystem. Through the Biocodex research program, an orphan medicinal product was developed, and marketing authorization was โ€ฆSee details»

Our locations - Biocodex.com

Biocodex operates in more than 100 countries worldwide, strengthening its local presence through 16 wholly-owned subsidiaries combined with a network of robust partnerships and distributors.See details»

REMINDER โ€“ Biocodex Microbiota Foundation invites Canadian โ€ฆ

3 days ago MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects โ€ฆSee details»

Our Products - Biocodex.com

Biocodex develops, manufactures and distributes world-class pharmaceutical products and health solutions for patients combining in house R&D and scientific partnerships, production โ€ฆSee details»

Our focus - Biocodex.com

Biocodex is committed to improving the health and well-being of patients and consumers around the world at every stage of their lives, focusing on three areas of expertise: microbiota care, โ€ฆSee details»

Our science - Biocodex USA

Biocodex has invested in start-ups since 2016 and become a key player in the French biotech ecosystem. We focus mainly on companies developing innovative therapeutics with probiotics โ€ฆSee details»

Home Page - biocodex.fi

Biocodex is a family-owned company founded more than 60 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded โ€ฆSee details»

Page Home - Biocodex Canada

Biocodex est une entreprise familiale fondée il y a plus de 70 ans pour commercialiser la première souche de levure probiotique du monde : Saccharomyces boulardii CNCM I-745®.See details»

About Us - Biocodex.com

Biocodex is a family-owned company founded 70 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded its โ€ฆSee details»

Biocodex in USA - Biocodex USA

Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its โ€ฆSee details»

International - Biocodex.com

Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its โ€ฆSee details»

Biocodex at a glance

Present in more than 100 countries, Biocodexโ€™s employees are committed to serving millions of patients around the world. We apply our expertise to developing and marketing a wide range โ€ฆSee details»

Biocodex USA committed to healthcare with passion and โ€ฆ

Biocodex is a family-owned company founded more than 60 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded โ€ฆSee details»

Our science - biocodex.fi

Biocodex has invested in start-ups since 2016 and become a key player in the French biotech ecosystem. We focus mainly on companies developing innovative therapeutics with probiotics โ€ฆSee details»

Our science - Biocodex.com

Biocodex has invested in start-ups since 2016 and become a key player in the French biotech ecosystem. We focus mainly on companies developing innovative therapeutics with probiotics โ€ฆSee details»